Related references
Note: Only part of the references are listed.Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Kristy A. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Estrogens, regulation of p53 and breast cancer risk: a balancing act
D. Joseph Jerry et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Metformin: A Therapeutic Opportunity in Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2010)
Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Carlos A. Gonzalez et al.
EUROPEAN JOURNAL OF CANCER (2010)
Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer
N. Fortunati et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Interaction between menopausal status and obesity in affecting breast cancer risk
David P. Rose et al.
MATURITAS (2010)
Effect of Obesity on Breast Cancer Development
M. P. Cleary et al.
VETERINARY PATHOLOGY (2010)
Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk
Daniele Campa et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Obesity and Breast Cancer: The Estrogen Connection
Margot P. Cleary et al.
ENDOCRINOLOGY (2009)
STrengthening the REporting of Genetic Association studies (STREGA) - an extension of the STROBE statement
Julian Little et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Inflammation and cancer: Breast cancer as a prototype
Alberto Mantovani et al.
BREAST (2007)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
AMP-activated protein kinase in metabolic control and insulin signaling
Mhairi C. Towler et al.
CIRCULATION RESEARCH (2007)
Gastrointestinal stromal turnours overexpress fatty acid synthase
S. Rossi et al.
JOURNAL OF PATHOLOGY (2006)
AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer
Hiroyuki Motoshima et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Efficiency and power in genetic association studies
PIW de Bakker et al.
NATURE GENETICS (2005)
Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression
M Igata et al.
CIRCULATION RESEARCH (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
New roles for the LKB1→AMPK pathway
DG Hardie
CURRENT OPINION IN CELL BIOLOGY (2005)
AMP-activated protein kinase: balancing the scales
D Carling
BIOCHIMIE (2005)
Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
JA Menendez et al.
MEDICAL HYPOTHESES (2005)
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium
CS Carlson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Management of cellular energy by the AMP-activated protein kinase system
DG Hardie et al.
FEBS LETTERS (2003)
Regulation of fatty acid synthase expression in breast cancer by sterol regulatory, element binding protein-1c
YA Yang et al.
EXPERIMENTAL CELL RESEARCH (2003)
European prospective investigation into cancer and nutrition (EPIC):: study populations and data collection
E Riboli et al.
PUBLIC HEALTH NUTRITION (2002)
Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line
K Imamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
R Kaaks et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2001)
Dietary glycemic index and glycemic load, and breast cancer risk: A case-control study
LSA Augustin et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
